Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Ohio doctor starts new clinic with lower charges but doesn't accept insurance

Dr. James Brockman has taken on a new business model with his medical practice to maintain less overhead and avoid hassles with insurance companies and people who won't pay their bills. No insurance is accepted at his Affordable Health Care Center, which opened in April and offers visits starting at $45 and capped at $100 for more complicated cases.

10 Sep 2010

56% of Australians won’t vaccinate against Swine flu: Survey

Over fifty per cent of Australians were not vaccinated against the swine flu before winter arrived this year, with many of these people deliberately choosing not to be vaccinated.

9 Sep 2010

Aethlon Hemopurifier captures immunosuppressive exosomes from individuals with metastatic melanoma.

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that its researchers have demonstrated the ability of the Aethlon Hemopurifier® to capture immunosuppressive exosomes derived from individuals with metastatic melanoma.

9 Sep 2010

SDI's VaccineTrack data reports on season's flu vaccination

More than 690,000 Americans have already received this season's flu vaccine from their doctor, according to SDI's VaccineTrack data through Sept. 4. VaccineTrack provides syndicated weekly vaccine usage by physicians based on medical office electronic healthcare reimbursement claims data.

9 Sep 2010

Synthetic biology survey reveals need for attention towards addressing biosafety, biosecurity risks

Synthetic biology defined as the design and construction of new biological parts, devices, and systems or re-design of existing natural biological systems for useful purposes holds enormous potential to improve everything from energy production to medicine, with the global market projected to reach $4.5 billion by 2015.

9 Sep 2010

One-third of Americans experience Hospital Acquired Infection: Xenex Healthcare survey

Nearly one-third of Americans have experienced a Hospital Acquired Infection (HAI) or have a friend or relative who contracted one, according to a new survey from Xenex Healthcare. HAIs (such as C. diff, MRSA, staph infections and pneumonia) are the fourth leading cause of death in the U.S., according to the Centers for Disease Control and Prevention, and while hospitals have stepped up efforts to prevent these deadly infections, more needs to be done.

9 Sep 2010

Illegal drug usage in older people reduces quality of life: Research

Health and social services are facing a new challenge, as many illicit drug users get older and face chronic health problems and a reduced quality of life. That is one of the key findings of research published in the September issue of the Journal of Advanced Nursing.

9 Sep 2010

Researchers reveal surface protein alteration mechanism of mycoplasma bacteria

Pathogenic bacteria have evolved a variety of mechanisms to avoid being killed by the immune systems of the humans and animals they invade. Among the most sophisticated is that practised by mycoplasmas, which regularly change their surface proteins to confuse the immune system. Recent work in the group of Renate Rosengarten and Rohini Chopra-Dewasthaly at the University of Veterinary Medicine, Vienna has revealed surprising new details of the way they do so and at the same time raised important evolutionary questions.

9 Sep 2010

Groups call for mandatory flu vaccinations for health workers

USA Today: "The American Academy of Pediatrics plans to call for all health workers to get flu vaccinations, saying unvaccinated doctors, nurses and other medical staffers pose a threat to patients. The academy, which represents 60,000 pediatricians, is the latest of several organizations that now back mandatory flu shots for health workers

9 Sep 2010

NovaBay Pharmaceuticals to deliver new data on Aganocide compounds at ICAAC Conference

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, will deliver four poster presentations on its compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

9 Sep 2010

Researchers discover low levels of DHA associated with chronic neurodegenerative disease

UC Irvine researchers have discovered that markedly depleted amounts of an omega-3 fatty acid in brain tissue samples from Alzheimer's patients may be due to the liver's inability to produce the complex fat, also contained in fish-oil supplements.Low levels of docosahexaenoic acid, or DHA, have been associated with the chronic neurodegenerative disease affecting millions of Americans, but no cause had been identified.

9 Sep 2010

Indiana State Legislators holds hearing to improve methamphetamine production

Today, the Indiana State Legislature's Criminal Law and Sentencing Policy Study Committee is holding a hearing on how the state can improve its policies for preventing the illegal diversion of pseudoephedrine (PSE) a key ingredient in leading cold and allergy medicines for methamphetamine production.

9 Sep 2010

CVS Caremark offers $5 million in free flu shots for uninsured patients

CVS Caremark announced today that it will partner with Direct Relief USA to offer up to $5 million in free flu shots to community clinic and health center patients who lack health insurance.

9 Sep 2010

ImmuneRegen's Homspera with Scancell's ImmunoBody technology improves immune response for cancer

ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. today announced that treatment with its lead compound, Homspera, in combination with a DNA vaccine utilizing Scancell's ImmunoBody technology significantly improved the immune response of the vaccine in an animal model.

8 Sep 2010

Data finds low risk of serious complications in 2009 H1N1 infection

An analysis of data from influenza cases in Wisconsin indicates individuals with 2009 H1N1 infections were younger than those with H3N2 (2007-2008), and that the risk of most serious complications was not higher in adults or children with 2009 H1N1 compared with recent seasonal strains, according to a study in the September 8 issue of JAMA.

8 Sep 2010

New vaccines fact sheet released by Research!America

Research!America is highlighting the vital importance of vaccines with a new fact sheet in its Investment in Research Saves Lives and Money series. CDC recently reported that routine vaccination rates are increasing among teens aged 13-17, but for many diseases the vaccination rates are far below the CDC's recommended 90% mark. With kids heading back to school and flu season fast approaching, now is a good time to remind readers of the importance of vaccines and disease prevention.

8 Sep 2010

Phase 3 REALIZE study shows milestone in treatment development for hepatitis C

Vertex Pharmaceuticals Incorporated today announced that 65% of people overall achieved a sustained viral response (SVR or viral cure) with a telaprevir-based regimen in the pivotal Phase 3 REALIZE study, as compared to 17% of people in the control arm who received pegylated-interferon and ribavirin alone.

8 Sep 2010

Personalized reminders effective in encouraging seniors to get annual flu shots

Personalized post cards or phone calls can be effective in encouraging more seniors to get their annual flu shots, according to a new review of evidence. Professional facilitators are also successful at urging providers to perform a suite of preventive services, including flu shots for seniors.

8 Sep 2010

Study finds increase in emergency department usage among US patients

Only 45 percent of the 354 million annual visits for acute care in the United States are made to patients' personal physicians, as Americans increasingly make busy emergency departments, specialists or outpatient care departments their first point of contact for treatment of new health problems or a flare up of a chronic condition like asthma or diabetes.

8 Sep 2010

Forest Laboratories' ceftaroline fosamil receives FDA Advisory Committee approval for CABP and cSSSI

Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0 in favor of approval for complicated skin and skin structure infections (cSSSI).

8 Sep 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Ohio doctor starts new clinic with lower charges but doesn't accept insurance

56% of Australians won’t vaccinate against Swine flu: Survey

Aethlon Hemopurifier captures immunosuppressive exosomes from individuals with metastatic melanoma.

SDI's VaccineTrack data reports on season's flu vaccination

Synthetic biology survey reveals need for attention towards addressing biosafety, biosecurity risks

One-third of Americans experience Hospital Acquired Infection: Xenex Healthcare survey

Illegal drug usage in older people reduces quality of life: Research

Researchers reveal surface protein alteration mechanism of mycoplasma bacteria

Groups call for mandatory flu vaccinations for health workers

NovaBay Pharmaceuticals to deliver new data on Aganocide compounds at ICAAC Conference

Researchers discover low levels of DHA associated with chronic neurodegenerative disease

Indiana State Legislators holds hearing to improve methamphetamine production

CVS Caremark offers $5 million in free flu shots for uninsured patients

ImmuneRegen's Homspera with Scancell's ImmunoBody technology improves immune response for cancer

Data finds low risk of serious complications in 2009 H1N1 infection

New vaccines fact sheet released by Research!America

Phase 3 REALIZE study shows milestone in treatment development for hepatitis C

Personalized reminders effective in encouraging seniors to get annual flu shots

Study finds increase in emergency department usage among US patients

Forest Laboratories' ceftaroline fosamil receives FDA Advisory Committee approval for CABP and cSSSI

Industry Focus eBook - Forensics & Toxicology (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Industry Focus eBook - Forensics & Toxicology (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in